Načítá se...
Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy
A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral probene...
Uloženo v:
| Vydáno v: | JACC Case Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301499/ https://ncbi.nlm.nih.gov/pubmed/34316787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.07.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|